U.S. Markets closed

Nabriva Therapeutics plc (NBRV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3700-0.0500 (-3.52%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.84
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 312.0000
52 Week Low 31.3600
50-Day Moving Average 32.0985
200-Day Moving Average 33.5550

Share Statistics

Avg Vol (3 month) 32.26M
Avg Vol (10 day) 31.01M
Shares Outstanding 534.79M
Implied Shares Outstanding 6N/A
Float 24.78M
% Held by Insiders 11.59%
% Held by Institutions 113.22%
Shares Short (Apr 14, 2021) 42.72M
Short Ratio (Apr 14, 2021) 41.16
Short % of Float (Apr 14, 2021) 47.83%
Short % of Shares Outstanding (Apr 14, 2021) 47.81%
Shares Short (prior month Mar 14, 2021) 42.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 02, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec 02, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-1,315.42%

Management Effectiveness

Return on Assets (ttm)-54.18%
Return on Equity (ttm)-186.76%

Income Statement

Revenue (ttm)5.03M
Revenue Per Share (ttm)0.39
Quarterly Revenue Growth (yoy)638.70%
Gross Profit (ttm)-10.84M
EBITDA -65.71M
Net Income Avi to Common (ttm)-69.48M
Diluted EPS (ttm)-5.4090
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)41.38M
Total Cash Per Share (mrq)1.65
Total Debt (mrq)7.9M
Total Debt/Equity (mrq)23.84
Current Ratio (mrq)3.09
Book Value Per Share (mrq)1.57

Cash Flow Statement

Operating Cash Flow (ttm)-71.33M
Levered Free Cash Flow (ttm)-47.68M